Biomarkers in the "Omics" Era
A special issue of BioTech (ISSN 2673-6284).
Deadline for manuscript submissions: closed (31 July 2022) | Viewed by 22150
Special Issue Editors
Interests: precision medicine; patients stratification; prostate cancer; molecular signatures; androgen receptor; MYC; bromodomain; chromatin; transcriptomics; single cell; gene regulation; radiobiology
Special Issues, Collections and Topics in MDPI journals
Interests: hepato-biliary-pancreatic cancers; translational medicine; cancer risk factors; cancer biomarkers; cancer genetic; cancer biology; drug discovery; cancer treatment
Special Issue Information
The rapid development of high-throughput technologies has opened up a new “omics” era providing an unprecedented opportunity for scientists and clinicians to gain deeper insights into molecular mechanisms, even at single cell resolution. The analysis and integration of the data arising from these methodological approaches is revolutionizing daily clinical practice, moving the precision medicine paradigm forward. In this scenario, the identification of tissue and circulating molecular biomarkers with high sensitivity and specificity to be employed for diagnosis, prognosis, and treatment prediction will undoubtedly benefit patients, but only few have been successfully implemented into the clinic.
This Special Issue of BioTech includes research articles, short reports, and reviews focused on the employment of “omics” (e.g., genomics, epigenomics, transcriptomics, proteomics, metabolomics, lipidomics, microbiomics) technologies for biomarker development both at translational and clinical level.
Dr. Alfonso Urbanucci
Dr. Simona Tavolari
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. BioTech is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- gene signatures
- oncology
- free circulating DNA
- next-generation sequencing
- molecular biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
